Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RPS26P52 refers to a *pseudogene* related to ribosomal protein S26[7]. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional due to mutations or lack of regulatory elements. RPS26P52 is one of several processed (non-functional) pseudogenes for ribosomal proteins that are found dispersed through the human genome[3][5][6]. Unlike the active ribosomal protein S26 gene (RPS26), which encodes a protein that is part of the 40S ribosomal subunit and is implicated in protein synthesis and some disease processes[1][3][5], pseudogenes like RPS26P52 do **not** encode functional proteins or serve recognized biological functions. Notes on Target Validity: - RPS26P52 is **not a therapeutic target**—it is not a receptor, enzyme, transporter, nor does it have a functional role that could be pharmacologically manipulated. - The nomenclature indicates it is a *pseudogene*—which by definition, means it is generally non-coding and non-functional[7]. - No known biological functions, disease roles, drug interactions, or utility as a biomarker have been described for this pseudogene in available databases. - If you intended the query for the functional ribosomal protein S26 (RPS26), refer instead to that canonical gene, which is a genuine protein-coding gene involved in ribosome structure and has established disease links (such as Diamond-Blackfan anemia)[1][3][5]. Summary: RPS26P52 (ribosomal protein S26 pseudogene 52) is a non-functional, pseudogene variant related to ribosomal protein S26, with no defined biological function, disease relevance, drug interactions, or application as a therapeutic target[7][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ribosomal protein S26 pseudogene 52 (RPS26P52).